At $10.4 billion dollars, biotech giant Amgen's acquisition of Onyx is the fifth-largest biotech deal in history - and definitely won't be the last. This deal is a perfect illustration of why there’s so much money being made in biotech...
Nasdaq: HGSI
Article Index
Amgen (Nasdaq: AMGN) Deal Shows How to Find Biotech's Best Investments